Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytogenetically Normal Acute Myeloid Leukaemia at a Single Centre in South Africa.

Hematology/oncology and stem cell therapy - 23 May 2023

Jenkins Nicholas, Blanshard Lee-Ann, Stone Marian, Verburgh Estelle, Oosthuizen Jenna, Shires Karen

Abstract excerpt

BACKGROUND AND OBJECTIVES: The heterogeneous molecular landscape of cytogenetically normal acute myeloid leukemia (CN-AML) renders it an ongoing therapeutic challenge. The European LeukemiaNet (ELN) 2017 guidelines attempted to address this by guiding post-remission therapy according to six prognostically informative mutations. However, its applicability in a South African setting remains unclear due to limited...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Leukemia, Myeloid, Acute
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nuclear Proteins

Share to Nucleophosmin

Share to Prognosis

Share to South Africa

Source

Identifiers

PMID: 37363984
DOI: 10.56875/2589-0646.1087

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytogenetically Normal Acute Myeloid Leukaemia at a Single Centre in South Africa.PMID 37363984Read ↗

Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD).Semantic proximity Read ↗

Acute Myeloid Leukaemia with Normal Cytogenetics and NPM1-Mutation: Impact of Mutation Topography on OutcomesSemantic proximity Read ↗

Mutational landscape of AML with normal cytogenetics: biological and clinical implications.Semantic proximity Read ↗

Prevalence and Prognostic Impact of NPM1 Mutation in Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Cancer Centre in India.Semantic proximity Read ↗

Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis.Semantic proximity Read ↗

Genomic Landscape of Acute Myeloid Leukemia in a mixed African Cohort: A Pilot StudySemantic proximity Read ↗

The Evolving Genetics of AML: Implications for Practice in Albania and KosovoSemantic proximity Read ↗

Molecular therapy for acute myeloid leukaemia.Semantic proximity Read ↗

Prognostically important molecular markers in cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matterSemantic proximity Read ↗

When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matterSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.